{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:52:48Z","timestamp":1789419168909,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Proton pump inhibitors are frequently used (and often overused) medications with adverse effects including vitamin B12 deficiency,\n                      <jats:italic>Clostridium\u00a0difficile<\/jats:italic>\n                      colitis, and increased risk of chronic kidney disease. Erectile dysfunction is largely unrecognized as an adverse effect of proton pump inhibitors despite increasing evidence that proton pump inhibitors may contribute to impaired nitric oxide generation and endothelial dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 38-year-old Caucasian man with mild hypertension and no other significant medical history developed profound erectile dysfunction within 2\u00a0days of initiating over-the-counter omeprazole therapy, with erectile function rapidly normalizing following discontinuation of the drug. At the time of the episode, the patient was on a stable dose of lisinopril and was taking no other medications or supplements. In the 2\u00a0years following the episode, the patient has had no further erectile difficulties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Further study of erectile dysfunction as an adverse effect of proton pump inhibitors is needed. In the meantime, proton pump inhibitors should be considered as a potential cause of erectile dysfunction in healthy young patients and as a cause or contributor to erectile dysfunction in older patients in whom erectile dysfunction is often attributed to age or comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-021-02981-5","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T19:04:42Z","timestamp":1627067082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Theodore W.","family":"Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"issue":"25","key":"2981_CR1","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1021\/ja049607w","volume":"126","author":"JM Shin","year":"2004","unstructured":"Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc. 2004;126(25):7800.","journal-title":"J Am Chem Soc"},{"issue":"6","key":"2981_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1046\/j.1365-2036.2000.00768.x","volume":"14","author":"L Laine","year":"2000","unstructured":"Laine L, Ahnen D, McClain C, Solcia E, Welsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2000;14(6):651.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2981_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jhin.2017.08.017","volume":"98","author":"F Cao","year":"2018","unstructured":"Cao F, Chen CX, Wang M, et\u00a0al. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. J Hosp Infect. 2018;98(1):4.","journal-title":"J Hosp Infect"},{"key":"2981_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmj.e372","volume":"344","author":"H Khalili","year":"2012","unstructured":"Khalili H, Huang ES, Jacobson BC, Carmago CA, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ. 2012;344:372.","journal-title":"BMJ"},{"issue":"2","key":"2981_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, et\u00a0al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2981_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.hlc.2017.10.020","volume":"27","author":"TP Shiraev","year":"2018","unstructured":"Shiraev TP, Bullen A. Proton pump inhibitors and cardiovascular events: a systematic review. Heart Lung Circ. 2018;27(4):443\u201350.","journal-title":"Heart Lung Circ"},{"issue":"2","key":"2981_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amjmed.2006.06.010","volume":"120","author":"E Selvin","year":"2007","unstructured":"Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151.","journal-title":"Am J Med"},{"issue":"8","key":"2981_CR8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jacc.2003.11.041","volume":"43","author":"MM Fung","year":"2004","unstructured":"Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol. 2004;43(8):1405.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2981_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/archinte.166.2.213","volume":"166","author":"SA Grover","year":"2006","unstructured":"Grover SA, Lowensteyn I, Kaouache M, et\u00a0al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006;166(2):213.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2981_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0094-0143(21)00866-1","volume":"15","author":"AJ Wein","year":"1988","unstructured":"Wein AJ, Van Arsdalen KN. Drug-induced male sexual dysfunction. Urol Clin North Am. 1988;15(1):23.","journal-title":"Urol Clin North Am"},{"issue":"1 pt 1","key":"2981_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","volume":"29","author":"RH Grimm Jr","year":"1997","unstructured":"Grimm RH Jr, Grandits GA, Prineas RJ, et\u00a0al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29(1 pt 1):8.","journal-title":"Hypertension"},{"issue":"2","key":"2981_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/phar.2504","volume":"41","author":"M Nolde","year":"2021","unstructured":"Nolde M, Bahls M, Friedrich N, et\u00a0al. Association of proton pump inhibitor use and metabolites of the nitric oxide pathway: a cross-sectional study. Pharmacotherapy. 2021;41(2):198\u2013204.","journal-title":"Pharmacotherapy"},{"key":"2981_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.redox.2016.08.001","volume":"9","author":"LC Pinheiro","year":"2016","unstructured":"Pinheiro LC, Oliveira-Paula GH, Portella RL, Guimaraes DA, de Angelis CD, Tanus-Santos JE. Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction. Redox Biol. 2016;9:134\u201343.","journal-title":"Redox Biol"},{"key":"2981_CR14","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","volume":"118","author":"G Yepuri","year":"2016","unstructured":"Yepuri G, Sukhovershin R, Nazari-Shafti TZ, Petrascheck M, Ghebre YT, Cooke JP. Proton pump inhibitors accelerate endothelial senescence. Circ Res. 2016;118:e36\u201342.","journal-title":"Circ Res"},{"key":"2981_CR15","unstructured":"Omeprazole and erectile dysfunction\u2014an update. Bijiwerkingen Centrum Lareb."},{"issue":"6851","key":"2981_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/bmj.305.6851.451","volume":"305","author":"M Lindquist","year":"1992","unstructured":"Lindquist M, Edwards IR. Endocrine effects of omeprazole. BMJ. 1992;305(6851):451\u20132.","journal-title":"BMJ"},{"issue":"15","key":"2981_CR17","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0024-3205(00)00452-5","volume":"66","author":"Y Sarioglu","year":"2000","unstructured":"Sarioglu Y, Yildirim S, Utkan T, Yildirim MK, Uma S. Evidence of relaxant effect of omeprazole in rabbit corpus cavernosum in vitro. Life Sci. 2000;66(15):1411\u201321.","journal-title":"Life Sci"},{"key":"2981_CR18","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","volume":"108","author":"H Dayoub","year":"2003","unstructured":"Dayoub H, Achan V, Adimoolam S, et\u00a0al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis. Circulation. 2003;108:3042\u20137.","journal-title":"Circulation"},{"issue":"8","key":"2981_CR19","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/jgh.13750","volume":"32","author":"R Batchelor","year":"2017","unstructured":"Batchelor R, Gilmartin JF, Kemp W, Hopper I, Liew D. Dementia, cognitive impairment and proton pump inhibitor therapy: a systematic review. J Gastroenterol Hepatol. 2017;32(8):1426.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02981-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T19:26:41Z","timestamp":1627068401000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02981-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"27 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no financial or nonfinancial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}